Mentari Therapeutics
San Francisco, California, United States · Biotechnology, Health Care, Therapeutics
Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine to deliver freedom from this debilitating and undertreated neurological condition. Mentari's lead programs target PACAP, a newly validated target that is mechanistically independent from CGRP.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- San Francisco, California, United States
- Employees
- 2
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- mentaritx.com
- Company page
Recent activity at Mentari Therapeutics
About Mentari Therapeutics: questions and answers
What does Mentari Therapeutics do?
Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine to deliver freedom from this debilitating and undertreated neurological condition. Mentari's lead programs target PACAP, a newly validated target that is mechanistically independent from CGRP.
Where is Mentari Therapeutics headquartered?
Mentari Therapeutics is headquartered in San Francisco, California, United States.
How many employees does Mentari Therapeutics have?
Mentari Therapeutics has about 2 employees.
What is the latest news on Mentari Therapeutics?
On Jul 22, 2026, Mentari Therapeutics secures $200 million in a private placement to further its migraine prevention pipeline, backed by leading healthcare investors.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy